Skip to content
Testmottagningen logo
en
sv
Testmottagningen logo
S3B

Stockholm3 – Biopsy cutoff

Biopsy cutoff is the threshold value in the Stockholm3 test risk score that determines whether a man should be further investigated for prostate cancer, in which case this is done, for example, with magnetic resonance imaging (MRI) or prostate biopsy.

Where is the cutoff?

In Swedish guidelines, the cutoff value is set at:

  • Over 11% – risk of clinically significant prostate cancer (Gleason ≥7)

This means that if your Stockholm3 risk score is over 11%, further investigation is recommended according to national guidelines.

Why is the cutoff important?

The cutoff value of 11% is scientifically established based on clinical studies to balance:

  • High detection of dangerous cancer
  • Low proportion of unnecessary biopsies
Clinical use

The biopsy cutoff result is used as a clear decision support in primary care. What is often referred to as the “Biopsy Cutoff” in medical reports is precisely this 11% limit.

Remember: Your risk score should always be interpreted in consultation with a doctor, along with other factors such as age, family history and imaging diagnostics.